U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 305

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:36691759
GRCh38:
Chr22:36295713
MYH9E1093KAutosomal dominant nonsyndromic hearing loss 17Uncertain significance
(May 21, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr22:36697022
GRCh38:
Chr22:36300976
LOC126863137, MYH9R905CMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Jun 22, 2022)
criteria provided, conflicting interpretations
3.
GRCh37:
Chr22:36692980
GRCh38:
Chr22:36296934
MYH9S1061CAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Uncertain significance
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr22:36684790
GRCh38:
Chr22:36288744
MYH9K1585QAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Conflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr22:36681727
GRCh38:
Chr22:36285681
MYH9R1751WAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not specified
Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr22:36690302
GRCh38:
Chr22:36294256
MYH9E1225Knot provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Uncertain significance
(Mar 30, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr22:36723520
GRCh38:
Chr22:36327475
MYH9not specified, not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
Autosomal dominant nonsyndromic hearing loss 17
Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr22:36692870
GRCh38:
Chr22:36296824
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Mar 2, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr22:36684996
GRCh38:
Chr22:36288950
MYH9Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr22:36716829
GRCh38:
Chr22:36320784
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Nov 24, 2021)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr22:36681149
GRCh38:
Chr22:36285103
MYH9not provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr22:36710226
GRCh38:
Chr22:36314181
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr22:36696305
GRCh38:
Chr22:36300259
LOC126863137, MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr22:36688248
GRCh38:
Chr22:36292202
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr22:36689355
GRCh38:
Chr22:36293309
MYH9Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Benign/Likely benign
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr22:36696887
GRCh38:
Chr22:36300841
LOC126863137, MYH9Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Likely benign
(Apr 7, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr22:36716245
GRCh38:
Chr22:36320200
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Benign/Likely benign
(Mar 26, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr22:36684333
GRCh38:
Chr22:36288287
MYH9R1633WAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Uncertain significance
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr22:36695043
GRCh38:
Chr22:36298997
MYH9L1008VMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Nov 15, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr22:36684859
GRCh38:
Chr22:36288813
MYH9L1562VAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Conflicting interpretations of pathogenicity
(Jun 27, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr22:36700168
GRCh38:
Chr22:36304122
MYH9R755Cnot provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(Mar 10, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr22:36691584
GRCh38:
Chr22:36295538
MYH9T1151MAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Conflicting interpretations of pathogenicity
(Feb 21, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr22:36714278
GRCh38:
Chr22:36318233
MYH9V401IMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Jun 27, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr22:36681805
GRCh38:
Chr22:36285759
MYH9R1725WMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Uncertain significance
(Jan 8, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr22:36690298
GRCh38:
Chr22:36294252
MYH9R1226LAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Uncertain significance
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr22:36681336
GRCh38:
Chr22:36285290
MYH9H1772Ynot provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Uncertain significance
(Mar 30, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr22:36689870
GRCh38:
Chr22:36293824
MYH9D1293NAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Uncertain significance
(Dec 28, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr22:36684347
GRCh38:
Chr22:36288301
MYH9S1628LMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr22:36692968
GRCh38:
Chr22:36296922
MYH9A1065TMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Uncertain significance
(Mar 8, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr22:36690247
GRCh38:
Chr22:36294201
MYH9S1243LAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Uncertain significance
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr22:36700135
GRCh38:
Chr22:36304089
MYH9G766Snot provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Uncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr22:36685336
GRCh38:
Chr22:36289290
MYH9A1451VAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Uncertain significance
(Jul 6, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr22:36745004
GRCh38:
Chr22:36348959
MYH9N93Snot provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Uncertain significance
(Oct 4, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr22:36696236
GRCh38:
Chr22:36300190
LOC126863137, MYH9Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr22:36702020
GRCh38:
Chr22:36305974
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Apr 30, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr22:36714312
GRCh38:
Chr22:36318267
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Benign/Likely benign
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr22:36690298
GRCh38:
Chr22:36294252
MYH9R1226Pnot provided, Autosomal dominant nonsyndromic hearing loss 17Conflicting interpretations of pathogenicity
(Dec 2, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr22:36696878
GRCh38:
Chr22:36300832
LOC126863137, MYH9not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Benign/Likely benign
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr22:36689391
GRCh38:
Chr22:36293345
MYH9A1360GAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Uncertain significance
(Nov 2, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr22:36691533
GRCh38:
Chr22:36295487
MYH9Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr22:36690158
GRCh38:
Chr22:36294112
MYH9D1273NMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Oct 19, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr22:36680315
GRCh38:
Chr22:36284269
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr22:36681801
GRCh38:
Chr22:36285755
MYH9R1726HAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not specified
Uncertain significance
(Aug 3, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr22:36690274
GRCh38:
Chr22:36294228
MYH9K1234RMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided, Inborn genetic diseases,
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Uncertain significance
(Oct 6, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr22:36718520
GRCh38:
Chr22:36322475
MYH9A220Vnot specified, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Uncertain significance
(Apr 12, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr22:36695098
GRCh38:
Chr22:36299052
MYH9Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorderConflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr22:36688093
GRCh38:
Chr22:36292047
MYH9D1428GAutosomal dominant nonsyndromic hearing loss 17, MYH9-related disorderUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr22:36684815
GRCh38:
Chr22:36288769
MYH9Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorderUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr22:36684413
GRCh38:
Chr22:36288367
MYH9S1606LAutosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder, Proteinuria,
not specified
Conflicting interpretations of pathogenicity
(Mar 3, 2022)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr22:36681953
GRCh38:
Chr22:36285907
MYH9R1703QAutosomal dominant nonsyndromic hearing loss 17, Inborn genetic diseases, not provided,
MYH9-related disorder
Conflicting interpretations of pathogenicity
(Sep 2, 2022)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr22:36678828
GRCh38:
Chr22:36282782
MYH9Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorderUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr22:36678810
GRCh38:
Chr22:36282764
MYH9not provided, Autosomal dominant nonsyndromic hearing loss 17, not specified,
MYH9-related disorder
Conflicting interpretations of pathogenicity
(Aug 19, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr22:36678519
GRCh38:
Chr22:36282473
MYH9Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorderConflicting interpretations of pathogenicity
(May 3, 2017)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr22:36745167
GRCh38:
Chr22:36349122
MYH9S39GAutosomal dominant nonsyndromic hearing loss 17, MYH9-related disorderUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr22:36715645
GRCh38:
Chr22:36319600
MYH9G350SMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr22:36715610
GRCh38:
Chr22:36319565
MYH9D361EMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr22:36708282
GRCh38:
Chr22:36312237
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr22:36708267
GRCh38:
Chr22:36312222
MYH9A519TMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
59.
GRCh37:
Chr22:36708232
GRCh38:
Chr22:36312187
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr22:36701091
GRCh38:
Chr22:36305045
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr22:36684375
GRCh38:
Chr22:36288329
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Feb 2, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr22:36681787
GRCh38:
Chr22:36285741
MYH9I1731VMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr22:36681272
GRCh38:
Chr22:36285226
MYH9K1793RMYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(May 17, 2022)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr22:36678719
GRCh38:
Chr22:36282673
MYH9E1960KMYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(Jan 10, 2023)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr22:36678466
GRCh38:
Chr22:36282420
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr22:36678441
GRCh38:
Chr22:36282395
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr22:36744935
GRCh38:
Chr22:36348890
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Aug 19, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr22:36737460
GRCh38:
Chr22:36341415
MYH9H149NMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr22:36737457
GRCh38:
Chr22:36341412
MYH9I150VMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
70.
GRCh37:
Chr22:36698671
GRCh38:
Chr22:36302625
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr22:36690236
GRCh38:
Chr22:36294190
MYH9R1247CMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr22:36712669
GRCh38:
Chr22:36316624
MYH9M425LMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr22:36705446
GRCh38:
Chr22:36309401
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Oct 11, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr22:36697720
GRCh38:
Chr22:36301674
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
Autosomal dominant nonsyndromic hearing loss 17
Uncertain significance
(Dec 27, 2021)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr22:36689895
GRCh38:
Chr22:36293849
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17, not provided
Conflicting interpretations of pathogenicity
(Mar 21, 2022)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr22:36685222
GRCh38:
Chr22:36289176
MYH9M1489TMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr22:36684328
GRCh38:
Chr22:36288282
MYH9MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(Jul 28, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr22:36680552
GRCh38:
Chr22:36284506
MYH9R1830HMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr22:36678701
GRCh38:
Chr22:36282655
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr22:36678641
GRCh38:
Chr22:36282595
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
81.
GRCh37:
Chr22:36678389
GRCh38:
Chr22:36282343
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr22:36783918
GRCh38:
Chr22:36387873
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr22:36722673
GRCh38:
Chr22:36326628
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr22:36702101
GRCh38:
Chr22:36306055
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr22:36697604
GRCh38:
Chr22:36301558
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr22:36697082
GRCh38:
Chr22:36301036
LOC126863137, MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr22:36691583
GRCh38:
Chr22:36295537
MYH9MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(May 25, 2022)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr22:36689393
GRCh38:
Chr22:36293347
MYH9MYH9-related disorder, not provided, Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(Aug 12, 2022)
criteria provided, conflicting interpretations
89.
GRCh37:
Chr22:36682866
GRCh38:
Chr22:36286820
MYH9E1653DMYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr22:36678075
GRCh38:
Chr22:36282029
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr22:36677384
GRCh38:
Chr22:36281338
MYH9MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr22:36680233
GRCh38:
Chr22:36284187
MYH9A1891TAutosomal dominant nonsyndromic hearing loss 17, not provided, MYH9-related disorder,
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Uncertain significance
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr22:36689462
GRCh38:
Chr22:36293416
MYH9Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17, not provided
Benign/Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr22:36705382
GRCh38:
Chr22:36309337
MYH9Kidney disorder, not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss,
Autosomal dominant nonsyndromic hearing loss 17
Conflicting interpretations of pathogenicity
(Apr 9, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr22:36700210
GRCh38:
Chr22:36304164
MYH9not provided, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17
Likely benign
(May 10, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr22:36708087
GRCh38:
Chr22:36312042
MYH9Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder, not provided
Conflicting interpretations of pathogenicity
(Apr 12, 2018)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr22:36680140
GRCh38:
Chr22:36284094
MYH9not provided, Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
Likely benign
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr22:36688158
GRCh38:
Chr22:36292112
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Oct 12, 2021)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr22:36702050
GRCh38:
Chr22:36306004
MYH9Autosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Likely benign
(Aug 11, 2021)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr22:36680499
GRCh38:
Chr22:36284453
MYH9L1848VAutosomal dominant nonsyndromic hearing loss 17, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, not provided
Benign/Likely benign
(Nov 16, 2021)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination